Immunogenetic and clinical characterization of slowly progressive IDDM

Diabetes Care

Volumn 16, Issue 5, 1993, Pages 780-788

  Kobayashi, Tetsuro ^a   Tamemoto, Koji ^b   Nakanishi, Koji ^b   Kato, Norihiro ^b   Okubo, Minoru ^b   Kajio, Hiroshi ^b   Sugimoto, Tadao ^b   Murase, Toshio ^b   Kosaka, Kinori ^b  

^a TORANOMON HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CHILD; DISEASE COURSE; FAMILY HISTORY; FEMALE; GENETIC VARIABILITY; HUMAN; IMMUNOGENETICS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; ONSET AGE; PANCREAS ISLET CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AUTOANTIBODIES; BASE SEQUENCE; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; GENE FREQUENCY; HAPLOTYPES; HEMOGLOBIN A, GLYCOSYLATED; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMAN; ISLETS OF LANGERHANS; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T;

EID: 0027263221     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.16.5.780     Document Type: Article

References (39)

1. Gorsuch AN, Spencer KM, Lister J, Mc-Nally JM, Dean BM, Bottazzo GF: Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet 2:1363-65, 1981
2. Eisenbarth GS: Type 1 diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314:1360-68, 1986
3. Kida K, Gotoh Y, Kaino Y, Matsuda H, Kobayashi T: Use of human insulin (recombinant DNA) in a type I diabetic child with autoimmunity: a case report, J Jpn Diabetes Soc 27 (Suppl. 2):259-62, 1984
4. Irvine W, McCallum C, Gray R, Duncan L: Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycemic agents. Lancet 1:1025-27, 1977
5. Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K: Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of type 1 diabetes. Diabetes 36:510-17, 1987
6. Spencer KM, Tarn A, Dean BM, Lister J, Bottazzo GF: Fluctuating islet-cell auto-immunity in unaffected relatives of patients with insulin-dependent diabetes. Lancet 1:764-66, 1984
7. McCulloch DK, Klaff LJ, Schoenfeld SL, Greenbaum CJ, Benson EA, Palmer JP: Subclinical beta cell dysfunction is not always progressive among first degree relatives of type I diabetics: five year follow-up of the Seattle family study (Abstract). Diabetes 38 (Suppl. 2):90A, 1989
8. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark A, Sundkvist G: Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 32:387-95, 1989
9. Barbosa J, Rich SS: Genetics of insulin-dependent diabetes. In Immunogenetics of Endocrine Disorders. New York, Liss, 1988, p. 163-202
10. Kobayashi T, Nakanishi K, Sugimoto T, Itoh T, Murase T, Kosaka K, Tsuji K: Maleness as risk factor for slowly progressive IDDM. Diabetes Care 12:7-11, 1989
11. Kobayashi T, Sawano S, Itoh T, Sugimoto T, Takahashi S, Tanaka T, Suwa S: Islet-cell antibodies in insulin-dependent and non-insulin-dependent diabetics in Japan: their prevalence and clinical significance. In Clinico -Genetic Genesis of Diabetes Mellitus. Mimura G, Baba S, Gotoh Y, Kobberling J, Eds. Amsterdam, Excerpta Med., 1982, p. 150-60
12. Urakami T, Miyamoto Y, Fujita H, Kitagawa T: Type 1 (insulin-dependent) diabetes in Japanese children is not a uniform disease. Diabetoiogia 32:312-15, 1989
13. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-57, 1979
14. Matsuda A, Kuzuya T: Urine C-peptide after recovery from diabetic ketoacidosis - an index of insulin dependency. Diabetes Care 5:581-84, 1982
15. Gjessing HJ, Matzen LE, Feber OK, Froland A: Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes. Dtabetologia 32:305-11, 1989
16. Pinchera A, Fenzi G: Endocrine autoimmune disease. In Endocnnology. 3rd ed. Degroot LJ, Cahill GF Jr, Odell WD, Martini L, Potts JT Jr, Nelson DH, Steinberger E, Winegrad A, Eds. New York, Grune & Stratton, 1979, p. 2063-83
17. Kobayashi T, Sugimoto T, Itoh T, Kosaka K, Tanaka T, Suwa S, Sato K, Tsuji K: The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method. Diabetes 35:335-40, 1986
18. Boitard C, Bonifacio E, Bottazzo GF, Gleichmann H, Molenaar J: Immunology and diabetes workshops: report on the third international (stage 3) workshop on standardisation of cytoplasmic islet cell antibodies. Diabetologia 31:451-52, 1988
19. Nakanishi K, Kobayashi T, Miyashita H, Ohkubo M, Sugimoto T, Murase T, Kosaka K, Inouye K, Kono M: Relationships between islet cell antibodies, residual beta-cell function and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay. Metabolism 39:925-30, 1990
20. Maeda M, Murayama H, Ishi H, Ota M, Tsuji K, Inoko H: A simple and rapid method for HLA-DQA1 genotyping by digestion of PCR-amplified DNA with allele specific restriction endonuclease. Tissue Antigens 34:290-98, 1989
21. Uryu N, Maeda M, Ota M, Tsuji K, Inoko H: A simple and rapid method for HLA-DRB and -DQB typing by digestion of PCR-amplified DNA with allele specific restriction endonuclease. Tissue Antigens 35:20-31, 1990
22. Trucco G, Fritsch R, Giorda R, Trucco M: Rapid detection of IDDM susceptibility with HLA-DQB alleles as markers. Diabetes 38:1617-22, 1989
23. Nomura N, Ota M, Tsuji K, Inoko H: HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 38:53-59, 1991
24. Terasaki PI: HLA-DR joint report. In Histocompatibility Testing. Terasaki PI, Ed. Los Angeles, CA, UCLA Tissue Typing Laboratory, 1980, p. 506
25. Kobayashi T: Immunology and immunogenetics of type I-diabetes in Japan. IDF Bull 35:34-37, 1990
26. Nakanishi K, Kobayashi T, Sugimoto T, Murase T, Itoh T, Kosaka K: Predictive value of insulin autoantibodies for further progression of beta cell dysfunction in non-insulin-dependent diabetics. Diabetes Res 9:105-109, 1988
27. Schiffrin A, Suissa S, Poussier P, Guttmann R, Weitzner G: Prospective study of predictors of β-cell survival in type I diabetes. Diabetes 37:920-25, 1988
28. Yoon J-W, Melez KA, Smathers PA, Archer JA, Steinberg AD: Virus-induced diabetes in autoimmune New Zealand mice. Diabetes 32:755-59, 1983
29. Karjalainen J, Salmela P, Ilonen J, Sercel H-M, Knip M: A comparison of childhood and adult type I diabetes mellitus. N Engl J Med 320:881-86, 1989
30. Khalil I, Deschamps I, Lepage V, Al-Daccak R, Degos L, Hors J: Dose effect of cis- and trans-encoded HLA-DQ aB heterodimers in IDDM susceptibility. Diabetes 41:378-84, 1992
31. Nakanishi K, Kobayashi T, Miyashita H, Okubo M, Sugimoto T, Murase T, Kosaka K, Tsusi K: Effect of class 1 and class II on beta-cell damage in insulin-dependent diabetes mellitus (IDDM) [Abstract]. J Jpn Diabetes Soc 33 (Suppl. 1): 255, 1990
32. Allison J, Cambell IL, Morahan G, Mandie TE, Harrison LC, Miller JFAP: Diabetes in transgenic mice resulting from overexpression of class I histocompatibility molecules in pancreatic β-cells. Nature Lond 333:529-33, 1988
33. Kajio H, Kobayashi T, Nakanishi K, Ohkubo M, Sugimoto T, Murase T, Itoh T, Kosaka K: Islet cell antibodies (ICA) and beta-cell functions in first-degree relatives of insulin-dependent diabetics: a prospective study (Abstract). Diabetes Res Clin Pract 5 (Suppl. 1):S255, 1988
34. Chem MM, Anderson VE, BarbosaJ: Empirical risk for insulin-dependent diabetes (IDD) in sibs. Diabetes 31:1115-18, 1982
35. Groop LC, Bottazzo GF, Doniach D: Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes 35:237-41, 1986
36. Stern MP, Ferrell RE, Rosenthal M, Haffner SM, Hazuda H: Association between NIDDM, Rh blood group, and haptoglobin phenotype. Diabetes 35: 387-91, 1986
37. Matsushita T, Tsukada T, Nakayama T, Kitamura M, Kobayashi T, Nakanishi K, Murase T: Haptoglobin phenotype in insulin-dependent diabetes and non-insulin-dependent diabetes in Japanese population (in Japanese). Physico-chem Biol 33:52, 1989
38. Wagener DK, Sacks JM, Lapone RE, Macgregor JM: The Pittsburgh study of insulin-dependent diabetes mellitus: risk for diabetes among relatives of IDDM Diabetes 31:136-44, 1982
39. Bottazzo GF, Cudworth AG, Moul DJ, Doniach D, Festenstein H: Evidence fora primary autoimmune type of diabetes mellitus (type 1b). Br Med J 2:1253-55, 1978